Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-γ activation

Biochemical and Biophysical Research Communications

Volumn 356, Issue 4, 2007, Pages 1024-1030

  Moriuchi, Akie ^a,b   Yamasaki, Hironori ^a,b   Shimamura, Mika ^b   Kita, Atsushi ^a   Kuwahara, Hironaga ^a   Fujishima, Keiichiro ^a,b   Satoh, Tsuyoshi ^a   Fukushima, Keiko ^a,b   Fukushima, Tetsuya ^a   Hayakawa, Takao ^c   Mizuguchi, Hiroyuki ^c   Nagayama, Yuji ^d   Abiru, Norio ^a   Kawasaki, Eiji ^b   Eguchi, Katsumi ^a  

^a Graduate School of Biomedical Sciences   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adiponectin; PPAR ; Telmisartan

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN; CANDESARTAN; LUCIFERASE; PARTIAL AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TELMISARTAN;

ADENOVIRUS; ADIPOCYTE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG MECHANISM; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REPORTER GENE; STIMULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; PPAR GAMMA; TRANS-ACTIVATION (GENETICS);

ADENOVIRIDAE;

EID: 34047170834     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.084     Document Type: Article

References (35)

1. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116 (2006) 1784-1792
2. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., and Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 68 (2004) 975-981
3. Yatagai T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., Nakai Y., and Ishibashi S. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52 (2003) 1274-1278
4. Lopez I.P., Milagro F.I., Marti A., Moreno-Aliaga M.J., Martinez J.A., and De Miguel C. High-fat feeding period affects gene expression in rat white adipose tissue. Mol. Cell Biochem. 275 (2005) 109-115
5. Pitombo C., Araujo E.P., De Souza C.T., Pareja J.C., Geloneze B., and Velloso L.A. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J. Endocrinol. 191 (2006) 699-706
6. Bullen Jr. J.W., Bluher S., Kelesidis T., and Mantzoros C.S. Regulation of adiponectin and its receptors in response to development of diet induced obesity in mice. Am. J. Physiol. Endocrinol. Metab. (2006) 15-30
7. Simons P.J., van den Pangaart P.S., van Roomen C.P., Aerts J.M., and Boon L. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human preadipocytes are potent leptin producers. Cytokine 32 (2005) 94-103
8. Kita A., Yamasaki H., Kuwahara H., Moriuchi A., Fukushima K., Kobayashi M., Fukushima T., Takahashi R., Abiru N., Uotani S., Kawasaki E., and Eguchi K. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 331 (2005) 484-490
9. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., and Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001) 2094-2099
10. Kriketos A.D., Gan S.K., Poynten A.M., Furler S.M., Chisholm D.J., and Campbell L.V. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 27 (2004) 629-630
11. Reinehr T., Roth C.L., Alexy U., Kersting M., Kiess W., and Andler W. Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents. Int. J. Obes. (Lond.) 29 (2005) 362-368
12. Hammarstedt A., Sopasakis V.R., Gogg S., Jansson P.A., and Smith U. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia 48 (2005) 96-104
13. Barth N., Langmann T., Scholmerich J., Schmitz G., and Schaffler A. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways. Diabetologia 45 (2002) 1425-1433
14. Seo J.B., Moon H.M., Noh M.J., Lee Y.S., Jeong H.W., Yoo E.J., Kim W.S., Park J., Youn B.S., Kim J.W., Park S.D., and Kim J.B. Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J. Biol. Chem. 279 (2004) 22108-22117
15. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
16. Henriksen E.J., Jacob S., Kinnick T.R., Teachey M.K., and Krekler M. Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 38 (2001) 884-890
17. Clasen R., Schupp M., Foryst-Ludwig A., Sprang C., Clemenz M., Krikov M., Thone-Reineke C., Unger T., and Kintscher U. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 46 (2005) 137-143
18. Dahlof B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., de Faire U., Fyhrquist F., Ibsen H., Kristiansson K., Lederballe-Pedersen O., Lindholm L.H., Nieminen M.S., Omvik P., Oparil S., and Wedel H. Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
19. Julius S., Kjeldsen S.E., Weber M., Brunner H.R., Ekman S., Hansson L., Hua T., Laragh J., McInnes G.T., Mitchell L., Plat F., Schork A., Smith B., and Zanchetti A. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363 (2004) 2022-2031
20. Furuhashi M., Ura N., Higashiura K., Murakami H., Tanaka M., Moniwa N., Yoshida D., and Shimamoto K. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42 (2003) 76-81
21. Negro R., Formoso G., and Hassan H. The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients. J. Endocrinol. Invest. 29 (2006) 957-961
22. Kurtz T.W. Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator. Acta Diabetol. 42 (2005) S9-S16
23. Benson S.C., Pershadsingh H.A., Ho C.I., Chittiboyina A., Desai P., Pravenec M., Qi N., Wang J., Avery M.A., and Kurtz T.W. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43 (2004) 993-1002
24. Takahashi M., Arita Y., Yamagata K., Matsukawa Y., Okutomi K., Horie M., Shimomura I., Hotta K., Kuriyama H., Kihara S., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 861-868
25. Mizuguchi H., and Kay M.A. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum. Gene. Ther. 10 (1999) 2013-2017
26. Koizumi N., Mizuguchi H., Hosono T., Ishii-Watabe A., Uchida E., Utoguchi N., Watanabe Y., and Hayakawa T. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim. Biophys. Acta 1568 (2001) 13-20
27. Sakaue H., Ogawa W., Matsumoto M., Kuroda S., Takata M., Sugimoto T., Spiegelman B.M., and Kasuga M. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J. Biol. Chem. 273 (1998) 28945-28952
28. Rosen E.D., and Spiegelman B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16 (2000) 145-171 58:20
29. Perera R.J., Marcusson E.G., Koo S., Kang X., Kim Y., White N., and Dean N.M. Identification of novel PPARgamma target genes in primary human adipocytes. Gene. 369 (2006) 90-99 58:20
30. Xu Y., Mirmalek-Sani S.H., Yang X., Zhang J., and Oreffo R.O. The use of small interfering RNAs to inhibit adipocyte differentiation in human preadipocytes and fetal-femur-derived mesenchymal cells. Exp. Cell Res. 312 (2006) 1856-1864
31. Tamori Y., Masugi J., Nishino N., and Kasuga M. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51 (2002) 2045-2055
32. Schupp M., Clemenz M., Gineste R., Witt H., Janke J., Helleboid S., Hennuyer N., Ruiz P., Unger T., Staels B., and Kintscher U. Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity. Diabetes 54 (2005) 3442-3452
33. Yoshida T., Yamagishi S., Nakamura K., Matsui T., Imaizumi T., Takeuchi M., Koga H., Ueno T., and Sata M. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia 49 (2006) 3094-3099
34. Mori Y., Oana F., Matsuzawa A., Akahane S., and Tajima N. Short-term effect of bezafibrate on the expression of adiponectin mRNA in the adipose tissues: a study in spontaneously type 2 diabetic rats with visceral obesity. Endocrine 25 (2004) 247-251
35. Hiuge A., Tenenbaum A., Maeda N., Benderly M., Kumada M., Fisman E.Z., Tanne D., Matas Z., Hibuse T., Fujita K., Nishizawa H., Adler Y., Motro M., Kihara S., Shimomura I., Behar S., and Funahashi T. Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level. Arterioscler. Thromb. Vasc. Biol. (2006) 58:20